Peter Sandner

12PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical virologyGroundwater quality processes and contaminated land assessmentCardiology (incl. cardiovascular diseases)Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 24, 2026
sGC stimulator BAY 41-8543 improves survival and ventricular function in a rat model of doxorubicin-induced cardiomyopathy with nephrotic syndrome.

|Jun 25, 2026
Pharmacological activation of NO-cGMP signalling attenuates metabolic dysfunction-associated steatohepatitis.

|Sep 09, 2023
The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 Rats.

Jan R Kraehling, Agnes Benardeau, Tibor Schomber

|Jul 24, 2023
Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation.

Carina Mauersberger, Hendrik B Sager, Jana Wobst

|May 12, 2023
Identification and characterization of the new generation soluble guanylate cyclase stimulator BAY-747 designed for the treatment of resistant hypertension.

Frank Wunder, Johannes-Peter Stasch, Andreas Knorr

|Dec 22, 2021
Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator.

Irina V Zabbarova, Youko Ikeda, Mark G Kozlowski

Pageof 2

Frequent Collaborators

2 joint publications

Robert Feil

1 joint publications

Daniel Stehle

1 joint publications

Shalini Murali Krishnan

1 joint publications

Jörg Hüser